Related Experiment Video
Updated: Aug 13, 2026
05:56
Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Hepatitis C -- identifying patients with progressive liver injury
1Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Hepatology (Baltimore, Md.)
|February 1, 2006
Summary
Hepatitis C progression varies greatly among patients. Host and viral factors, including genetics and lifestyle, influence liver disease severity and outcomes.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Hepatitis C virus (HCV) infection course is variable, ranging from minimal liver disease to cirrhosis and hepatocellular carcinoma.
- Both host-related factors (age, gender, immune status, alcohol) and viral elements influence HCV disease progression.
- Recent research implicates genetic polymorphisms in disease severity.
Purpose of the Study:
- To review current knowledge on factors driving progressive liver injury in Hepatitis C patients.
- To consolidate understanding of host and viral determinants of HCV disease progression.
- To inform treatment strategies and identify new therapeutic targets.
Main Methods:
- Literature review of studies on Hepatitis C disease progression.
- Analysis of host factors (demographics, lifestyle, genetics) associated with fibrosis.
- Examination of viral factors, including specific protein contributions to liver injury.
Main Results:
- Established general factors like age, gender, immune status, and alcohol consumption significantly impact HCV progression.
- Genetic polymorphisms in various genes are increasingly recognized as key determinants of liver fibrosis.
- Specific viral proteins are being investigated for their role in promoting liver disease severity.
Conclusions:
- Understanding the multifaceted determinants of HCV progression is crucial for effective patient management.
- Identifying key host and viral factors can optimize current treatment approaches.
- Further research into these factors may reveal novel therapeutic targets for Hepatitis C.
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...